Kebal 2500 Injection contains Methylcobalamin 2500 mcg, a biologically active form of vitamin B12 essential for neurological function and hematopoiesis. This injectable formulation is indicated for the treatment of vitamin B12 deficiency, which may present as pernicious anemia, neuropathies, or other conditions associated with inadequate cobalamin levels. Methylcobalamin plays a crucial role in the synthesis of methionine from homocysteine, thereby supporting DNA synthesis and neuronal repair. Kebal 2500 Injection is administered intramuscularly or intravenously, ensuring rapid bioavailability and effective correction of deficiency states. It is particularly beneficial in patients with malabsorption syndromes, chronic alcoholism, or those undergoing long-term use of medications that interfere with vitamin B12 absorption. The high dose of 2500 mcg facilitates prompt replenishment of tissue stores and symptomatic relief. Adverse effects are uncommon but may include mild injection site reactions or hypersensitivity. Caution is advised in patients with known hypersensitivity to cobalamin or any component of the formulation. Kebal 2500 Injection should be used under medical supervision with appropriate monitoring of hematologic and neurologic parameters to assess therapeutic response and avoid potential complications.